Rate My Professor Silvana Obici

Silvana Obici, MD, is Professor of Medicine and Division Chief of Endocrinology and Metabolism in the Department of Medicine at the Renaissance School of Medicine at Stony Brook University. She serves as Medical Director of the Diabetes Services at Stony Brook Medicine. Dr. Obici received her medical degree from the University Degli Studi di Napoli Federico II in 1981. Her early training included research fellowships at the Center for Cancer Research in 1981 and Dipartimento di Medicina Molecular & Biotech in Molecular Medicine in 1984, a postdoctoral fellowship at the Institute of Cancer Research, Columbia University in 1990, an internal medicine residency at NYU Langone Medical Center in 1998, and a fellowship in endocrinology, diabetes, and metabolism at Montefiore Medical Center in 2000. She holds board certifications in Endocrinology, Diabetes, and Metabolism from the American Board of Internal Medicine since 2000 and in Obesity Medicine from the American Board of Obesity Medicine since 2017.

Prior to her current roles at Stony Brook, Dr. Obici was an Associate Professor at the University of Cincinnati College of Medicine from 2005 to 2017. Her research specializes in endocrinology, with a focus on the central nervous system regulation of glucose homeostasis, insulin action, obesity, and diabetes. She has produced 76 research outputs, including highly influential publications such as "Endogenous glucose production is inhibited by the adipose-derived protein Acrp30" (The Journal of Clinical Investigation, 2001; 1418 citations), "Hypothalamic insulin signaling is required for inhibition of glucose production" (Nature Medicine, 2002; 1205 citations), "Hypothalamic KATP channels control hepatic glucose production" (Nature, 2005; 840 citations), "Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production" (The Journal of Clinical Investigation, 2003; 832 citations), and more recent works like "Impact of bariatric surgery on the development of diabetic microvascular and macrovascular complications" (Surgical Endoscopy, 2021) and "A big-data approach to understanding metabolic rate and response to obesity in laboratory mice" (eLife, 2020). With over 13,857 citations documented on ResearchGate, her contributions have significantly advanced understanding in metabolic regulation and clinical endocrinology.